DOCSLIB.ORG

ADHD Medication and Treatment Free Downloads the Latest Information on Managing Medication, Starting Behavior Therapy, Evaluating Alternative Treatments, and More

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ADHD Medication and Treatment Free Downloads the Latest Information on Managing Medication, Starting Behavior Therapy, Evaluating Alternative Treatments, and More The Ultimate Guide to ADHD MEveryethingd you neied cto knaow abtout miedoicationn options, achieving optimal benefits, and overcoming side effects. Includes MEDICATION TRACKING LOGS BY THE EDITORS OF WITH LAURIE DUPAR, PMHNP, AND WILLIAM DODSON, M.D. Expert eBook A trusted source of advice and information for families touched by attention-deficit disorder— and a voice of inspiration to help people with ADHD find success at home, at school, and on the job. additudemag.com/shop TERMS OF USE FOUNdER: Ellen Kingsley (1951-2007) Copyright © 2018 by New Hope Media. All rights reserved. Editor IN ChIEF: Susan Caughman No part of this report may be reproduced or transmitted Editor: Wayne Kalyn in any form or by any means, electronic or mechanical, including photocopying, recording, faxing, e-mailing, staff posting online, or by any information storage and retrieval consulting creativE Director: Joseph Caserto system, without written permission from the Publisher. consulting art Director: Ron Anteroinen Managing Editor: Eve Gilman All trademarks and brands referred to herein are the Reporter: Devon Frye SENIOR Digital Editor: Janice Rodden property of their respective owners. All references to SOCIAL MEdIA Editors: Rebecca Brown Wright, Penny Williams ADDitude magazine and ADDitudeMag.com are trade- Digital MARKETING Director: Anni Rodgers marks of New Hope Media. Advertising: Anne Mazza Circulation: Sue Sidler CONTACT INFORMATION COPy Editor: Gene Jones WEB Editor: Hope Goodrich New Hope Media 646-366-0830 contributing Editors: 108 West 39th St, Suite 805 Carol Brady, Ph.D., and John Taylor, Ph.D. (Children) New York, NY 10018 Edward M. Hallowell, M.D. (Life) Sandy Maynard, M.S. (Coaching) Michele Novotni, Ph.D. (Adults) LEGAL NOTICES Ann Dolin, M.Ed., and Sandra F. Rief, M.A. (Education) ADDitude does not provide medical advice, diagnosis, or AdministrativE assistant: Alex Viola treatment. The information offered here is for informa- tional purposes only and is not intended to substitute or replace professional medical advice, diagnosis, or treat- scientific advisory board ment. Always consult with your physician or other quali- Russell Barkley, Ph.d. Peter Jensen, M.d. fied health-care professional or educational consultant Medical University of The REACH Institute for questions about your health and education, or the South Carolina New York, NY health and education of your child and family members. Charleston, SC harold Koplewicz, M.d. Do not disregard, avoid, or delay obtaining medical or Thomas E. Brown, Ph.d. New York University Medical School health related advice from your health-care professional University of Southern California New York, NY because of something you have read here. Los Angeles, CA Sandy Newmark, M.d. William dodson, M.d. Osher Center for If you think you may have a medical emergency, call your Dodson ADHD Center Integrative Medicine, doctor or 911 immediately. ADDitude does not recom- Greenwood Village, CO University of California San Francisco, CA mend or endorse any specific tests, physicians, products, Ross W. Greene, Ph.d. procedures, opinions, or other information that may be Lives in the Balance Michele Novotni, Ph.d. mentioned in ADDitude publications or websites. Reliance Portland, ME The Villages, FL on any information provided by ADDitude is solely at your Edward M. hallowell, M.d. Roberto Olivardia, Ph.d. own risk. The Hallowell Center Harvard Medical School Sudbury, MA Boston, MA Stephen P. hinshaw, Ph.d. J. Russell Ramsay, Ph.d. University of California Perelman School of Medicine Berkeley, CA University of Pennsylvania Philadelphia, PA Peter Jaksa, Ph.d. ADD Center of America Jerome Schultz, Ph.d. Chicago, IL Harvard Medical School Boston, MA The Ultimate Guide to ADHD MedicationEverything you need to know about medication options, achieving optimal benefits, and overcoming side effects. Get the Right Diagnosis (and Treatment) The numbers tell the story: According to the Centers for Disease Con - trol, 6.4 million children ages 4-17 have been diagnosed with ADHD, and it doesn’t go away after puberty. Roughly two-thirds of children with ADHD grow up to be adults with ADHD. Today, about 8 million American adults have ADHD, though only a quarter of those have a formal diag - nosis. The good news is that there are safe, effective treatments for the disorder. The best ADHD treatment strategies are multimodal ones— combinations of several different, complementary approaches that work together to reduce symptoms. For many people, this ideal combination includes diet, exercise, meditation, and/or ADHD stimulants. Experts know, from years of research and many studies, that stimulant medica- tions are effective. They improve the core symptoms of ADHD—impul- sivity, hyperarousal, and distractibility—in some 70-80 percent of the people who take them. Nail Down the Diagnosis A thorough evaluation and correct diagnosis are the foundation of 3 successful treatment. A faulty diagnosis leads to treatments that don’t improve symptoms or, in some cases, make them worse. Doctors fre- quently mistake ADHD for other disorders—generalized anxiety dis - order, depression, bipolar disorder, and even OCD—so it is important that your doctor use all the tools available to assess and diagnose the correct condition. Diagnosis should include the following steps: taking a medical history to rule out physical causes of the symptoms; meeting the symptom guidelines of ADHD in the DSM-5; interviewing key people in the pa- tient’s life about behaviors; filling out rating scales to compare those behaviors with the normative average; and assessing for co-occurring conditions, such as depression, anxiety, learning disabilities, and oth - ers. Studies suggest that 50 to 90 percent of children, and approximately 85 percent of adults, diagnosed with ADHD have one or more co-occur- ring conditions. Medication and Dose When you and your doctor are confident of the diagnosis, and you de- cide to start medication, understand that you must work closely with your doctor to find the optimal medication and dose. There are two classes of stimulants—methylphenidate and amphetamine. Every per- son has a biological preference for one or the other class, but it is only through trial and error—taking methylphenidate and then, in separate trial, taking amphetamine—that a doctor can determine which one will work best. Stimulants do not work for 20-30 percent of people diag - nosed with ADHD. When they don’t, a doctor will consider using a non- stimulant medication to improve symptoms. The optimal dose of an ADHD stimulant is not determined by age, weight, FREE Download: gender, or severity of symptoms. It is determined by three factors that 9 Rules for Using ADHD are unique to each individual: how efficiently the medication is absorbed Medications Safely in the GI tract, how efficiently the medication is metabolized, and how http://additu.de/safemeds efficiently the medication passes across the blood-brain barrier. Experts agree that the right dose of stimulant will change throughout a patient’s life. The American Academy of Pediatrics recommends ad - justing a child’s dose once a year to achieve symptom management. After age 16, a person usually settles into an optimal dose, which, in most cases, does not change for the rest of his or her life. When thinking about starting a on ADHD medication, it is key that a The Ultimate Guide to ADHD Medication from the editors of 4 patient know what to expect from various medication choices and what to do when the medication doesn’t produce positive results. (“Under- standing ADHD Medications,” on pages 8 and 9, will give you a step-by- step overview of the process of using ADHD medications.) How to Monitor a Medication’s Effectiveness After you start taking an ADHD medication, you want to make sure that symptoms are improving without side effects—mood changes, head- aches, nausea, poor appetite, and so on. Monitoring behavior and physi- cal symptoms is key to knowing when a medication is working and when it isn’t. (The best tools for monitoring medication are the “Home Medication Log” and the “Observation Log” on pages 17 and 18 of this booklet.) This is especially important for younger children who can’t articulate what they are feeling, but also for adults who may not realize how their symptoms impact others. Expert WEBINAR: Remember that the optimal dose will probably need to be adjusted as a patient grows and matures. Hormonal changes alter the effectiveness How to Use and Adjust of ADHD medication. Stimulants Safely http://additu.de/ Below are the most common signs that a medication is doing what it management should. You may notice other signs unique to your specific challenges. If you’re not sure which improvements to look for, stick to these guide- lines. If you see them even if some side effects remain, you are on the way to optimizing the medication’s effectiveness. > Sustained focus. If the medication is starting to work, you will be able to focus for longer periods of time than you used to. This doesn’t mean hyperfocus or “zombie focus”—just a sustained focus that you can direct to where you want it to go, and that makes you more productive. > Less impulsivity. If your medication is working, you’ll notice less im- pulsivity—both physical and verbal. You will interrupt people or jump out of your seat less often. You will notice that your thoughts are less impulsive, too—you are less distracted by “brain chatter.” > Improved mood. When ADHD medication is optimized, a person typically has an improved overall mood. He is less stressed, with less anxiety—usually shown by higher productivity and fewer social challenges. > Greater attention to detail. Details become more important—instead The Ultimate Guide to ADHD Medication from the editors of 5 of skipping a step in directions, you will catch small mistakes before they happen.
Load more

Recommended publications
  • ADHD Parents Medication Guide Revised July 2013
    ADHD Parents Medication Guide Revised July 2013 Attention-Deficit/Hyperactivity Disorder Prepared by: American Academy of Child & Adolescent Psychiatry and American Psychiatric Association Supported by the Elaine Schlosser Lewis Fund Physician: ___________________________________________________ Address: ___________________________________________________ ___________________________________________________ ___________________________________________________ Phone: ___________________________________________________ Email: ___________________________________________________ ADHD Parents Medication Guide – July 2013 2 Introduction Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by difficulty paying attention, excessive activity, and impulsivity (acting before you think). ADHD is usually identified when children are in grade school but can be diagnosed at any time from preschool to adulthood. Recent studies indicate that almost 10 percent of children between the ages of 4 to 17 are reported by their parents as being diagnosed with ADHD. So in a classroom of 30 children, two to three children may have ADHD.1,2,3,4,5 Short attention spans and high levels of activity are a normal part of childhood. For children with ADHD, these behaviors are excessive, inappropriate for their age, and interfere with daily functioning at home, school, and with peers. Some children with ADHD only have problems with attention; other children only have issues with hyperactivity and impulsivity; most children with ADHD have problems with all three. As they grow into adolescence and young adulthood, children with ADHD may become less hyperactive yet continue to have significant problems with distraction, disorganization, and poor impulse control. ADHD can interfere with a child’s ability to perform in school, do homework, follow rules, and develop and maintain peer relationships. When children become adolescents, ADHD can increase their risk of dropping out of school or having disciplinary problems.
    [Show full text]
  • Sensory Processing in Children with ADHD: a Classroom Study and Rational Item Analysis Jason Mathison Philadelphia College of Osteopathic Medicine, [email protected]
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Philadelphia College of Osteopathic Medicine: DigitalCommons@PCOM Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Psychology Dissertations Student Dissertations, Theses and Papers 2012 Sensory Processing in Children with ADHD: A Classroom Study and Rational Item Analysis Jason Mathison Philadelphia College of Osteopathic Medicine, [email protected] Follow this and additional works at: http://digitalcommons.pcom.edu/psychology_dissertations Part of the Psychology Commons Recommended Citation Mathison, Jason, "Sensory Processing in Children with ADHD: A Classroom Study and Rational Item Analysis" (2012). PCOM Psychology Dissertations. Paper 212. This Dissertation is brought to you for free and open access by the Student Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been accepted for inclusion in PCOM Psychology Dissertations by an authorized administrator of DigitalCommons@PCOM. For more information, please contact [email protected]. Philadelphia College of Osteopathic Medicine Department of Psychology SENSORY PROCESSING IN CHILDREN WITH ADHD: A CLASSROOM STUDY AND RATIONAL ITEM ANALYSIS Jason Mathison Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Psychology May 2012 Committee Members' Signatures: George McCloskey, PhD, Chairperson Lisa Hain, PsyD Dr William Young Robert A DiTomasso, PhD, ABPP, Chair, Department of Psychology iii Acknowledgements This dissertation is dedicated to my wife, family, and supportive committee. First and foremost, to my wife Nicole Mathison, who has provided me with endless support, love, and patience with my difficult schedule and long commute over the last three years. During this process, she has lost her father, two grandmothers, and her beloved cat Ruby.
    [Show full text]
  • The Role of Inhibitory Control and Executive Functioning in Hyperactivity/ADHD
    ! "# $ % &'% () *' ("*+ '' +,"' -'*"+ --'*' . Dissertation for the Degree of Doctor of Philosophy in Psychology presented at Uppsala University in 2003 ABSTRACT Berlin, L. 2003. The Role of Inhibitory Control and Executive Functioning in Hyperactivity/ADHD. Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Social Sciences 120. 76 pp. Uppsala. ISBN 91-544-5513-1. This thesis examined inhibition, executive functioning and their possible relation to childhood problems of hyperactivity and inattention, in its clinical form referred to as Attention Deficit Hyper- activity Disorder (ADHD). Concurrent as well as longitudinal relations were of interest, and both clinical and non-clinical samples were studied. Study I demonstrated concurrent relations between executive inhibition and both hyperactivity and conduct problems in preschool. However, the relation between inhibition and conduct problems could be attributed to the large overlap between hyperactivity and conduct problems. In Study II, linear relations were found between executive inhibition and hyperactivity, whereas inhibition to the unfamiliar was related to hyperactivity, social initiative, as well as social anxiety. Non-linear analyses showed that children with high levels of both types of inhibition were at risk for developing low social initiative and social anxiety, whereas children with low levels of inhibition were at risk for developing hyperactivity, but at the same time protected from social anxiety. In Study III, executive inhibition was longitudinally related to ADHD symptoms in both school and at home for boys, but only in the school context for girls. Executive inhibition was also related to more general executive functioning deficits, and concurrent relations were found between executive functioning and ADHD symptoms, although in both cases only for boys.
    [Show full text]
  • Fact Sheet: Attention Deficit Hyperactivity Disorder (ADHD) Topics
    Fact Sheet: Attention Deficit Hyperactivity Disorder (ADHD) Topics MAJOR CHARACTERISTICS OTHER CHARACTERISTICS ADULT OUTCOME SUBTYPES PREVALENCE ETIOLOGIES TREATMENT MORE INFORMATION - SUGGESTED READINGS MORE INFORMATION - SUGGESTED READINGS FOR TEACHERS Attention-deficit hyperactivity disorder (ADHD) is the current term for a specific developmental disorder seen in both children and adults that is comprised of deficits in behavioral inhibition, sustained attention and resistance to distraction, and the regulation of one’s activity level to the demands of a situation (hyperactivity or restlessness). This disorder has had numerous different labels over the past century, including hyperactive child syndrome, hyperkinetic reaction of childhood, minimal brain dysfunction, and attention deficit disorder (with or without hyperactivity). MAJOR CHARACTERISTICS The predominant features of this disorder include: 1. Impaired response inhibition, impulse control, or the capacity to delay gratification. This is often noted in the individual’s inability to stop and think before acting; to wait one’s turn while playing games, conversing with others, or having to wait in line; to interrupt their responding quickly when it becomes evident that their actions are no longer effective; to resist distractions while concentrating or working; to work for larger, longer-term rewards rather than opting for smaller, more immediate ones; and inhibiting the dominant or immediate reaction to an event, as the situation may demand. 2. Excessive task-irrelevant activity or activity that is poorly regulated to the demands of a situation. Individuals with ADHD in many cases are noted to be excessively fidgety, restless, and “on the go.” They display excessive movement not required to complete a task, such as wriggling their feet and legs, tapping things, rocking while seated, or shifting their posture or position while performing relatively boring tasks.
    [Show full text]
  • CQR Treating ADHD
    Researcher Published by CQ Press, an Imprint of SAGE Publications, Inc. CQ www.cqresearcher.com Treating ADHD Are attention disorders overdiagnosed? nce viewed chiefly as affecting grade school-age children — chiefly hyperactive boys — attention deficit hyperactivity disorder (ADHD), which makes it difficult to focus attention and control Oimpulses, today is widely seen as a lifelong condition affecting both genders equally. As more and more children, adolescents and adults are diagnosed with ADHD, prescriptions for stimulants such as Ritalin and Adderall to fight the disorder are soaring. Yet many experts say that while stimulants temporarily ease symptoms, they do nothing to improve academic or work performance or social Blake Taylor, a student at the University of California, Berkeley, began taking medication for ADHD at age 5. skills, and some worry the condition is being overdiagnosed. At ADHD is widely seen today as a lifelong condition affecting both genders equally. the same time, non-drug treatments remain under-used. The in- creased availability of stimulants, which are addictive, is fueling I N prescription-drug abuse among students and others who do not THISREPORT S have ADHD but use the drugs as study aids or to get high. THE ISSUES ....................671 I BACKGROUND ................678 D CHRONOLOGY ................679 E AT ISSUE........................685 CQ Researcher • Aug. 3, 2012 • www.cqresearcher.com CURRENT SITUATION ........686 Volume 22, Number 28 • Pages 669-692 OUTLOOK ......................687 RECIPIENT OF SOCIETY OF PROFESSIONAL JOURNALISTS AWARD FOR BIBLIOGRAPHY ................690 EXCELLENCE N AMERICAN BAR ASSOCIATION SILVER GAVEL AWARD THE NEXT STEP ..............691 TREATING ADHD CQRe search er Aug. 3, 2012 THE ISSUES SIDEBARS AND GRAPHICS Volume 22, Number 28 • Is ADHD being over- One in 10 Children MANAGING EDITOR: Thomas J.
    [Show full text]
  • Children, Brains and Drugs
    Dan Shapiro, M.D. Developmental and Behavioral Pediatrics [email protected] www.parentchildjourney.com Concerns about misuse Legitimate use How to do it right Increased use of drugs for behavioral and emotional problems ◦ More drugs ◦ Broader use ◦ Younger treatment For ADHD: stimulants and non-stimulants For depression and anxiety: SSRIs and SNRIs For irritability, explosiveness; neuroleptics and mood stabilizers For everything: naturopathy/ homeopathy More diagnoses that lead to medication Broader diagnostic categories More doctors prescribing More public awareness Preschool treatment of ADHD Pediatric anxiety, depression, bipolar and temper dysregulation Conditions associated with Autism Validity of diagnostic categories in children Possible med side-effects; short-term and long- term Reluctance to seriously consider psychosocial interventions even when possibly safer and more effective than medication Tendency to think in terms of “one diagnosis-one treatment” rather than comprehensive assessment/comprehensive management of coexisting or underlying problems Brain basis for behavioral-emotional disorders Real impairment/real distress Growing evidence base for effectiveness Real long-term developmental benefits Neuroimaging Neurochemistry Neurogenetics ADHD: impulsivity, distractibility, hyperactivity Mood disorders: behavioral and mood instability, aggression, fears, excessive anxiety, depression Autism: anxiety, compulsions, perseveration, inflexibility, impulsivity, distractibility, explosiveness,
    [Show full text]
  • The Use of Medication in the Management of Attention-Deficit/ Hyperactive Disorder
    University of Northern Iowa UNI ScholarWorks Presidential Scholars Theses (1990 – 2006) Honors Program 1998 The use of medication in the management of attention-deficit/ hyperactive disorder Abigail S. Natvig University of Northern Iowa Let us know how access to this document benefits ouy Copyright ©1998 Abigail S. Natvig Follow this and additional works at: https://scholarworks.uni.edu/pst Part of the Special Education and Teaching Commons Recommended Citation Natvig, Abigail S., "The use of medication in the management of attention-deficit/hyperactive disorder" (1998). Presidential Scholars Theses (1990 – 2006). 116. https://scholarworks.uni.edu/pst/116 This Open Access Presidential Scholars Thesis is brought to you for free and open access by the Honors Program at UNI ScholarWorks. It has been accepted for inclusion in Presidential Scholars Theses (1990 – 2006) by an authorized administrator of UNI ScholarWorks. For more information, please contact [email protected]. "The Use of Medication in the Management of Attention-Deficit/ Hyperactive Disorder" Presidential Scholars Senior Thesis University of Northern Iowa Abigail S. Natvig Spring 1998 Sandra Alper 1-i- ,;y-4 ~ Faculty Advisor (date) Janet M. Rives 1 The Use of Medication in the Management of Attention-Deficit/ Hyperactive Disorder Attention-Deficit/ Hyperactive Disorder (ADHD) is a "consistently inconsistent" state of mental inattention with varying degrees of behavior abnormalities. Living with ADHD has been likened to "driving in the rain with bad windshield wipers. Everything in smudged and blurred and you're speeding along and its really frustrating not being able to see very well." ADHD has also been described as, "Like listening to a radio station with a lot of static and you have to strain to hear what's going on" or "Like trying to build a house of cards in a dust storm.
    [Show full text]
  • The Impact of Psychological Theory on the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults: a Scoping Review
    The Impact of Psychological Theory on the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults: A Scoping Review Author Rebecca E. Champ University of Huddersfield Huddersfield, UK Supervision Marios Adamou University of Huddersfield Huddersfield, UK Barry Tolchard University of Huddersfield Huddersfield, UK The Impact of Psychological Theory on the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults: A Scoping Review Abstract Psychological theory and interpretation of research are key elements influencing clinical treatment development and design in Attention Deficit Hyperactivity Disorder (ADHD). Research-based treatment recommendations primarily support Cognitive Behavioural Therapy (CBT), an extension of the cognitive behavioural theory, which promotes a deficit-focused characterisation of ADHD and prioritises symptom reduction and cognitive control of self-regulation as treatment outcomes. A wide variety of approaches have developed to improve ADHD outcomes in adults, and this review aimed to map the theoretical foundations of treatment design to understand their impact. A scoping review and analysis were performed on 221 documents to compare the theoretical influences in research, treatment approach, and theoretical citations. Results showed that despite variation in the application, current treatments characterise ADHD from a single paradigm of cognitive behavioural theory. A single theoretical perspective is limiting research for effective treatments for ADHD to address ongoing issues such as
    [Show full text]
  • Sluggish Cognitive Tempo) Russell A
    Barkley 1 Concentration Deficit Disorder (Sluggish Cognitive Tempo) Russell A. Barkley, Ph.D. Clinical Professor of Psychiatry and Pediatrics Medical University of South Carolina This Fact Sheet is based on a chapter to appear in the next edition of Dr. Barkley’s textbook, Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (4th edition). New York: Guilford Press. In press; expected publication date – December 2014. This chapter reviews the evidence for a second attention disorder that is distinct from yet overlaps with ADHD. Although this condition has been called Sluggish Cognitive Tempo (SCT) since the 1980s, I have recently recommended that the name be changed to Concentration Deficit Disorder (CDD) for various reasons, not the least of which is that it can be viewed by the public as pejorative, derogatory, or frankly offensive (Barkley, 2014; Saxbe & Barkley, 2014). While some prior reviewers of the evidence have suggested that the disorder be called attention deficit disorder, or ADD (Diamond, 2005; Milich & Roberts, 2012), and many clinicians have adopted this term for people who are primarily inattentive and have little or no evidence of hyperactive or impulsive behavior, it is not advisable to do so. Not the least reason for which is that ADD is the older term for ADHD dating back to DSM-III in 1980 and so resurrecting it as the name for a second attention disorder merely unnecessary creates confusion between these conditions which, as will be shown below, are quite different in a number of important features. The term SCT also implies that the neurocognitive dysfunction underlying the condition is well-known and supported by empirical evidence, and this is very far from the case at the moment.
    [Show full text]
  • Attention Deficit Identity Discourse: Exploring the Ableist Limitations and the Liberative Potential of the Onc Tested Adhd Self Nathan T
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital Commons@Wayne State University Wayne State University Wayne State University Dissertations 1-1-2017 Attention Deficit Identity Discourse: Exploring The Ableist Limitations And The Liberative Potential Of The onC tested Adhd Self Nathan T. Stewart Wayne State University, Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations Part of the Rhetoric Commons Recommended Citation Stewart, Nathan T., "Attention Deficit Identity Discourse: Exploring The Ableist Limitations And The Liberative Potential Of The Contested Adhd Self" (2017). Wayne State University Dissertations. 1881. http://digitalcommons.wayne.edu/oa_dissertations/1881 This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState. ATTENTION DEFICIT IDENTITY DISCOURSE: EXPLORING THE ABLEIST LIMITATIONS AND THE LIBERATIVE POTENTIAL OF THE CONTESTED ADHD SELF by NATHAN T. STEWART DISSERTATION Submitted to the Graduate School of Wayne State University, Detroit, Michigan in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY 2017 MAJOR: COMMUNICATION Approved By: Advisor Date © COPYRIGHT BY NATHAN T. STEWART 2017 All Rights Reserved DEDICATION To my Uncle Mark: You were here when I began this journey. For reasons we will never understand, you decided to leave this world on your own terms before I completed it. You, along with grandpa, were the only worthy father figures I had. For better or for worse, your decision challenged me to grow and adapt – to transform who I am and who I will become.
    [Show full text]
  • ADHD: Making the Invisible Visible
    ADHD: making the invisible visible An Expert White Paper on attention-deficit hyperactivity disorder (ADHD): policy solutions to address the societal impact, costs and long-term outcomes, in support of affected individuals S Young, M Fitzgerald, MJ Postma This project was initiated, facilitated and funded by Shire AG, and supported by the European Brain Council (EBC) and GAMIAN-Europe (Global Alliance of Mental Illness Advocacy Networks) ADHD: making the invisible visible An Expert White Paper on attention-deficit hyperactivity disorder (ADHD): policy solutions to address the societal impact, costs and long-term outcomes, in support of affected individuals Susan Young King’s College London, Institute of Psychiatry, UK Michael Fitzgerald Trinity College, Dublin, Ireland Maarten J Postma University of Groningen, the Netherlands This Expert White Paper project was initiated, facilitated and funded by Shire AG (www.Shire.com), and supported by the European Brain Council (EBC; www.europeanbraincouncil.org) and GAMIAN-Europe (Global Alliance of Mental Illness Advocacy Networks; www.gamian.eu). Medical writing support was provided by APCO Worldwide and Complete Medical Communications, and funded by Shire AG. Foreword: Making the invisible visible 2 Introduction 3 Executive summary 4 Chapter 1: Introduction to ADHD 6 Chapter 2: Impact, costs and long-term outcomes of ADHD 9 Chapter 3: Opportunities for improved recognition and management of ADHD 17 Annex 1: Participants in the European Expert Roundtable 23 Annex 2: Co-authors and contributors 24 Annex 3: References 26 Foreword: Making the invisible visible Brussels, 23 April 2013 In today’s world, mental health problems are becoming less and less of a priority on the political agenda.
    [Show full text]
  • ADULT ADHD Presentation
    ADHD and Executive Function: An Evolving Concept page 199 in syllabus David W. Goodman, MD Director, Adult Attention Deficit Disorder Center of Maryland Medical Director, Suburban Psychiatric Associates, LLC Assistant Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine Sponsored by the Neuroscience Education Institute Additionally sponsored by Fairleigh Dickinson University School of Psychology This activity is supported by educational grants from: Lilly USA, LLC; Otsuka America Pharmaceutical, Inc.; Pamlab, L.L.C.; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals International, Inc., U.S. Region and Lundbeck Pharmaceutical Services, LLC; Teva Pharmaceutical Industries Ltd. with additional support from: Assurex Health, Inc.; JayMac Pharmaceuticals, LLC; Neuronetics, Inc.. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com. Copyright © 2013 Neuroscience Education Institute. All rights reserved. Individual Disclosure Statement Faculty Author / Presenter David W. Goodman, MD, is the director of the Adult Attention Deficit Disorder Center of Maryland in Lutherville, the medical director of the Suburban Psychiatric Associates in Amherst/Orchard Park, NY, and an assistant professor in the department of psychiatry and behavioral sciences at Johns Hopkins School of Medicine in Baltimore, MD. Consultant/Advisor: Janssen-Ortho, Lundbeck, Novartis, Otsuka, Shire, Sunovion, Teva Copyright © 2013 Neuroscience Education Institute. All rights reserved. Learning Objectives
    [Show full text]